Helios Fairfax Partners Corporation
FFXXF
$2.20
-$0.1875-7.85%
| Weiss Ratings | FFXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | D- | |||
| Rating Factors | FFXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | FFXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.32 | |||
| Price History | FFXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -12.25% | |||
| 30-Day Total Return | -7.07% | |||
| 60-Day Total Return | -18.43% | |||
| 90-Day Total Return | -24.05% | |||
| Year to Date Total Return | -4.24% | |||
| 1-Year Total Return | -19.91% | |||
| 2-Year Total Return | -27.79% | |||
| 3-Year Total Return | -36.16% | |||
| 5-Year Total Return | -47.93% | |||
| 52-Week High % Change | -18.98% | |||
| 52-Week Low % Change | 17.16% | |||
| Price | FFXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $2.95 | |||
| 52-Week Low Price | $2.04 | |||
| 52-Week Low Price (Date) | Dec 31, 2024 | |||
| 52-Week High Price (Date) | Nov 21, 2024 | |||
| Valuation | FFXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 258.55M | |||
| Enterprise Value | -197.34M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.91 | |||
| Earnings Per Share Growth | -481.68% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -3.70 | |||
| Price/Book (Q) | 0.57 | |||
| Enterprise Value/Revenue (TTM) | 2.81 | |||
| Price | $2.20 | |||
| Enterprise Value/EBITDA (TTM) | 14.61 | |||
| Enterprise Value/EBIT | 2.33 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | FFXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 108.43M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | FFXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 647 846 1881 | |||
| Address | South Tower Toronto, ON M5J 2J2 | |||
| Website | www.heliosinvestment.com/helios-fairfax-partners | |||
| Country | Canada | |||
| Year Founded | 2016 | |||
| Profitability | FFXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 120.70% | |||
| Profit Margin | 139.82% | |||
| Management Effectiveness | FFXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -9.28% | |||
| Return on Equity | -- | |||
| Income Statement | FFXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -70.14M | |||
| Revenue Per Share | -$0.65 | |||
| Gross Profit (TTM) | -70.14M | |||
| EBITDA (TTM) | -13.51M | |||
| EBIT (TTM) | -84.66M | |||
| Net Income (TTM) | -98.08M | |||
| Net Income Avl. to Common (TTM) | -98.08M | |||
| Total Revenue Growth (Q YOY) | 143.95% | |||
| Earnings Growth (Q YOY) | 322.49% | |||
| EPS Diluted (TTM) | -0.91 | |||
| EPS Diluted Growth (Q YOY) | 286.50% | |||
| Balance Sheet | FFXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 456.40M | |||
| Cash Per Share (Q) | $4.21 | |||
| Total Current Assets (Q) | 476.26M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 457.44M | |||
| Current Ratio (Q) | 64.073 | |||
| Book Value Per Share (Q) | $4.23 | |||
| Total Assets (Q) | 477.76M | |||
| Total Current Liabilities (Q) | 7.43M | |||
| Total Debt (Q) | 510.00K | |||
| Total Liabilities (Q) | 20.31M | |||
| Total Common Equity (Q) | 457.44M | |||
| Cash Flow | FFXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -772.00K | |||
| Cash from Financing (TTM) | -28.93M | |||
| Net Change in Cash (TTM) | -88.87M | |||
| Levered Free Cash Flow (TTM) | 30.38M | |||
| Cash from Operations (TTM) | -59.56M | |||
